1359. Activity of Meropenem/Nacubactam Combination Against Gram-Negative Clinical Isolates: ROSCO Global Surveillance 2017

Rusudan Okujava(Roche (Switzerland)), Kenneth A. Bradley(Roche (Switzerland)), Claudia Zampaloni(Roche (Switzerland)), Sophie Magnet(Inserm), Fernando García-Alcalde(Roche (Switzerland)), Ian Morrissey, Nimmi Kothari, Ian Harding, Andreas Haldimann(Purdue University West Lafayette)
Open Forum Infectious Diseases
November 1, 2018
Cited by 13


Related Papers